The use of multiple parallel drugs (polypharmacy) is the use of several types of drugs in patients with type 1 who (World Health Organization, 2014b) drug use from 2 or more types (Haaijer-Ruskamp, & Stewart, Veehof, Meyboom-de Jong, 2000) by patients with cardiac failure associated with the disease, and many parallel have been drug into a risk factor only 2.04 per inconsistencies in medication (Riegel & Knafl, 2014) also found that elderly people who are at risk of multiple parallel medicines receive equal opportunities to uses 1.66 medications that the patient is not suitable (potentially inappropriate medication: PIM) (Chen, Lin Lin, Peng,, & Hwang, 2011) past studies found that many parallel have been drugs in patient suites.With cardiac failure causes inconsistency in the risks of medication or inappropriate drug use were found, which are not yet covered, the risk of behavior problems in the use of the drug in patients with cardiac failure.
การแปล กรุณารอสักครู่..
